Back to the main directory
Company Analysis / Equity
- Aegon - Capital outlook eases, earnings pressure remains by Whitman Howard
- Solutions 30 : the price of hypergrowth by MidCap Partners
- - A strengthening picture by Edison Investment Research
- OMC's: Mediocre Sept.'17 sales signal end to summer surge, (AKD Daily, Oct 04, 2017) by AKD Securities Limited
- PSA Daily Oct 4: Yen up, market sideways/Koike's field/SQE's new MOBA game/Panasonic, Tesla, good/Murata and LiBs /Subaru's US woes/JDI soars/Automation notes - Nikkei +0.06% by Pelham Smithers Associates Ltd
- - Growing high yield asset base by Edison Investment Research
- BGCP, Lutnick Unlocks Valuable Real Estate by The Edge Group LLC
- 4 HK, 130-Year-Old Conglomerate with Upcoming Premium Assets Spin, Insider Buying by The Edge Group LLC
- AAPL & DIS, The Tech Giant and the House of Mouse Have Potential Together... by The Edge Group LLC
- Grand Parade Investments (GPL) - All eyes on Burger King by Primaresearch
- - Sailing a steady course by Edison Investment Research
- Spin-Off Research - October 2017 Issue by Spin-Off Research
- Produce Investments (PIL LN, BUY, T/P 240p) - Digging in Well by Whitman Howard
- Maisons France Confort. Un soutien de poids by MidCap Partners
- Maisons France Confort. Support that counts by MidCap Partners
- - NEW-HOPE trial launched by Edison Investment Research
- - Positive year-end update by Edison Investment Research
- - Pixium seeks to address short Iris II lifespan by Edison Investment Research
- T. H. Data Flash - Chinese TAL Education Group – FY2Q18: Strong FY2Q18 Driven by High Growth of Course Offerings; Maintain BUY by T.H. Capital
- - Proximal solutions, multiple applications by Edison Investment Research
- Asatsu-DK (9747): Are the Chances of a Counter Bid by WPP (or Any Other Global Ad Agency) Being Underplayed? by Pelham Smithers Associates Ltd
- Transformational deal(s) by Merodis Equity Research
- Abzena (ABZA): Disappointing trading statement fully discounted by Hardman & Co
- PZ Cussons Nigeria Plc FQ1 18 - Cost pressures inform downward earnings review by ARM Securities Limited
- Advanced Oncotherapy (AVO): Technology advances & stronger balance sheet by Hardman & Co
- Solutions 30 : le prix de l'hypercroissance by MidCap Partners
- Atlantia could increase its offer price for Abertis up to €18/share. by Bankinter S.A.
- PSA Autos: September US Auto Sales – Performance Lifted by Replacement Demand, Fleet Sales, Discounts by Pelham Smithers Associates Ltd
- Avacta Group - Capital Network: Preliminary Results by proactiveinvestors
- A Closer Look at the Cut to Payout by Macro Strategy Advisors Pty Ltd
- PSA IHI (7013): Reducing Risk – ¥14bn Buffer Revisited by Pelham Smithers Associates Ltd
- NC, Zero Coverage $500m Split to Repeat 2012 Success? Happening this Month by The Edge Group LLC
- - Plenty in reserve by Edison Investment Research
- EFX, Why You Should Consider This as a Long-Term Investment by The Edge Group LLC
- Update on Management Changes by Great Lakes Review, a division of Wellington Shields & Co. LLC
- Despite a weak Q2, inherent strengths remain intact by AlphaValue
- MOSL: DR REDDY’S LABS (Neutral)-Mylan/Natco receives Copaxone 40mg approval-20mg TAD in November 2017 by Motilal Oswal
- Elis. Eurazeo cède 4,6% du capital by MidCap Partners
- Elis. Eurazeo sells 4.6% of capital by MidCap Partners
- PZ CUSSONS NIGERIA PLC Q1'17/18 - FY’18 begins with a loss as FX overhang persists by Vetiva Capital Management
- PSA Today Oct 5: Quiet day/Beer price to rise 10%?/SoftBank and Ride Hailing/Asatsu, WPP, Silchester and Bain - Nikkei +0.01% by Pelham Smithers Associates Ltd
- Good on paper, but... by AlphaValue
- - Positive trends in radiation treatment by Edison Investment Research
- T. H. Data Flash – Ctrip.com – August 2017 & Preliminary 3Q17: While the Bundled Sales Issue Lingers, 3Q17E is Likely to Be At Least In-line as SkyScanner Y/Y Growth Accelerated by T.H. Capital
- Initiation of Coverage: Forte Oil PLC - Powering an integrated energy model by Vetiva Capital Management
- Acquisition of Silego, a technological bet but financially risk-limited by AlphaValue
- More growth to be shaved off by AlphaValue
- ValiRx (VAL): Positive early data from VAL401 by Hardman & Co
- Sinclair Pharma (SPH): Demand growing in target markets by Hardman & Co
- MOSL: GUJARAT GAS (Sell)-Continued volatility in volumes and margin by Motilal Oswal